The PharmaTox Strategic Research Initiative aims to generate novel insight on effects of pharmaceuticals on human neurotoxicity and neurodevelopment.
PharmaTox was established January 1st 2015 as a prioritized research initiative supported by the Faculty of Mathematics and Natural Sciences.
The research projects within PharmaTox involve specialists in neurotoxicology, pharmacology, teratology, statistics, bioinformatics, epigenetics and epidemiology.
PharmaTox Master's Student: Ana Sulovic
Apr. 27, 2018 1:49 PM
Master's student Ana Sulovic defended her thesis on April 24th with the title "Mulige nevroutviklingsforstyrrelser av opioider - studier in vivo og i nevronkulturer"
Fulbright grant to PharmaTox PhD student Emil
Apr. 27, 2018 1:40 PM
Emil Aas Stoltenberg is a Fulbright grantee the academic year 2018-2019. Congratulations!
PharmaTox mini-sympsium: Receptors in pharmacotoxicity
Apr. 19, 2018 1:57 PM
PharmaTox are arranging a mini-sympisum with the topic receptors in pharmacotoxicity.
PharmaTox yearly report 2017
Apr. 9, 2018 9:06 AM
Read the PharmaTox yearly report to see what PharmaTox researchers achieved in 2017.
PharmaTox at Open day
Mar. 14, 2018 11:00 AM
PharmaTox post doc Kristina Gervin presented PharmaTox at Open day at the University of Oslo, March 8, 2018.